Francesco Sartini

Dr. Francesco Sartini

Università di Pisa
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Eye
Verified
Journal Article
Closed access
PDF file
FSFrancesco Sartini
Francesco Sartini
MFMichele Figus
Michele Figus
MNMarco Nardi
Marco Nardi
GCGiamberto Casini
Giamberto Casini
CPChiara Posarelli
Chiara Posarelli

Verified
Journal Article
Open access
PDF file
CPChiara Posarelli
Chiara Posarelli
FSFrancesco Sartini
Francesco Sartini
Giamberto CasiniGiamberto Casini
Giamberto Casini
APAndrea Passani
Andrea Passani
Mario Damiano ToroMario Damiano Toro
Mario Damiano Toro
MFMichele Figus
Michele Figus
Background: Optical coherence tomography (OCT) has recently been introduced in the operating theatre. The aim of this review is to present the actual role of microscope-integrated optical coherence tomography (MI-OCT) in ophthalmology. Method: A total of 314 studies were identified, following a literature search adhering to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. After full-text evaluation, 81 studies discussing MI-OCT applications in ophthalmology were included. Results: At present, three microscope-integrated optical coherence tomography systems are commercially available. MI-OCT can help anterior and posterior segment surgeons in the decision-making process, providing direct visualization of anatomic planes before and after surgical manoeuvres, assisting in complex cases, and detecting or confirming intraoperative complications. Applications range from corneal transplant to macular surgery, including cataract surgery, glaucoma surgery, paediatric examination, proliferative diabetic retinopathy surgery, and retinal detachment surgery. Conclusion: The use of MI-OCT in ophthalmic surgery is becoming increasingly prevalent and has been applied in almost all procedures. However, there are still limitations to be overcome and the technology involved remains difficult to access and use.

30 July 2020 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
FSFrancesco Sartini
Francesco Sartini
MFMichele Figus
Michele Figus
GCGiamberto Casini
Giamberto Casini
MNmarco nardi
marco nardi
CPChiara Posarelli
Chiara Posarelli

28 August 2020 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
FSFrancesco Sartini
Francesco Sartini
MMMartina Menchini
Martina Menchini
CPChiara Posarelli
Chiara Posarelli
Giamberto CasiniGiamberto Casini
Giamberto Casini
MFMichele Figus
Michele Figus
Bullous central serous chorioretinopathy (bCSCR) is a rare variant of the central serous chorioretinopathy, complicated by an exudative retinal detachment with shifting fluid. This systematic review aims to present the epidemiology, the pathogenesis, the clinical presentation, the imaging, the differential diagnosis, and the latest treatments of this disease. A total of 60 studies were identified following a literature search adhering to PRISMA guidelines. After full-text evaluation, 34 studies about bCSCR were included. bCSCR usually affects middle-aged men, and the principal risk factor is corticosteroid medications. Pathogenesis is related to an increased choroidal vessel and choriocapillaris permeability, with subsequent subretinal fluid accumulation, rich in fibrin, which may provoke the exudative retinal detachment. Clinical presentation and imaging are fundamental to distinguish bCSCR from other pathologies, avoiding unappropriated treatment. Corticosteroid withdraws (if assumed) and laser photocoagulation of leakage sites seen at angiography may speed up retinal reattachment. Verteporfin photodynamic therapy, transpupillary thermal therapy, oral eplerenone and scleral thinning surgery are other therapeutic options. An early diagnosis might prevent disease progression due to harmful medications as well as unnecessary surgery.

17 June 2021 in Acta Ophthalmologica
Verified
Journal Article
Open access
PDF file
FSFrancesco Sartini
Francesco Sartini
MMMartina Menchini
Martina Menchini
Pasquale LoiudicePasquale Loiudice
Pasquale Loiudice
MNMarco Nardi
Marco Nardi
MFMichele Figus
Michele Figus
GCGiamberto Casini
Giamberto Casini
Purpose: The purpose of this paper is to present a new surgical technique to remove vitreous cortex remnants.Methods: Non‐consecutive retrospective interventional case series.Results: When the posterior vitreous is split, its outermost layer may remain attached to the retina, developing vitreoschisis‐induced vitreous cortex remnants (VCR). Their role in macular pathology etiopathogenesis has been well documented; however, recently, it has been proposed that VCR also play a crucial role in proliferative vitreoretinopathy and consequent retinal redetachment. The prevalence of VCR is underestimated because triamcinolone acetonide is not routinely used for vitreous staining. Vitreous cortex remnants (VCR) removal is challenging, and several surgical techniques have been proposed. However, they require sclerotomy enlargement, material that may not be readily available, and manual fashioning. Alternatively, a diamond‐dusted membrane scraper (DDMS), already widely used in macular pathology treatment, can follow the contour of the retina, as it is a silicone tube, and remove VCR with its abrasive tip. A DDMS may also be introduced in the vitreous cavity through a standard trocar. Finally, the use of a DDMS provides predictable feedback, making the learning curve short. In this case series, 34 eyes affected by primary rhegmatogenous retinal detachment were enrolled. The retinal redetachment rate was 2.9% at six months of follow‐up, below the average literature value of 21%. No adverse events were reported.Conclusion: A DDMS can be suitable for use in VCR removal, although further studies are warranted to understand the indications and extent of this surgical technique for improving the management of rhegmatogenous retinal detachment.

13 January 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
FSFrancesco Sartini
Francesco Sartini
MMMartina Menchini
Martina Menchini
CPChiara Posarelli
Chiara Posarelli
Giamberto CasiniGiamberto Casini
Giamberto Casini
MFMichele Figus
Michele Figus
Adherence is crucial in medical glaucoma therapy, although half of the patients skip eyedrops. In recent years alternative drug-delivery systems have been developed. One of the most promising seems the contact lens (CL). This systematic review aims to present the in vivo efficacy of different CL drug-delivery systems. A total of 126 studies were identified following a literature search adhering to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. After full-text evaluation, 19 studies about CL drug-delivery systems were included. To date, the following drug-delivery systems have been investigated in vivo: drug-soaked CL, CL with physical barriers (vitamin E), molecularly imprinted CL, CL with implants, and nanoparticle-loaded CL. Nanoparticle-loaded CL and CL with implants seem the most promising drug-delivery systems, although initial burst drug release and patient acceptance may limit their widespread use in current practice. Clinical trials are warranted to understand the role of CL as a drug-delivery system in improving glaucomatous patient care.